A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
Clinical trial NCT01316107 · COMPLETED
Trial details
- NCT number
- NCT01316107
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-15
- Primary completion
- 2012-10-19
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.